Nanovaccine‐Mediated Cell Selective Delivery of Neoantigens Potentiating Adoptive Dendritic Cell Transfer for Personalized Immunization
- 24 June 2021
- journal article
- research article
- Published by Wiley in Advanced Functional Materials
- Vol. 31 (36) , 2104068
Abstract
Neoantigen vaccines and adoptive dendritic cell (DC) transfer are major clinical approaches to initiate personalized immunity in cancer patients. However, the immunization efficacy is largely limited by the in vivo trajectory including neoantigens’ access to resident DCs and DCs’ access to lymph nodes (LNs). Herein, an innovative strategy is proposed to improve personalized immunization through neoantigen‐loaded nanovaccines synergized with adoptive DC transfer. It is found that it enables selective delivery of neoantigens to resident DCs and macrophages by coating cancer cell membranes onto neoantigen‐loaded nanoparticles. In addition, the nanovaccines promote the secretion of chemokine C‐C motif ligand 2 (CCL2), CCL3, and C‐X‐C motif ligand 10 from macrophages, thus potentiating the access of transferred DCs to LNs. This immunization strategy enables coordinated delivery of identified neoantigens and autologous tumor lysate‐derived undefined antigens, leading to initiation of antitumor T cell immunity in a personalized manner. It significantly inhibits tumor growth in prophylactic and established mouse tumor models. The findings provide a new vision for potentiating adoptive cell transfer by nanovaccines, which may open the door to a transformative possibility for improving personalized immunization.Keywords
Funding Information
- Science and Technology Commission of Shanghai Municipality (19YF1457300)
- CAS-SAFEA International Partnership Program for Creative Research Teams (153631KYSB20190013)
- Natural Science Foundation of Shandong Province (ZR2019ZD25)
- Youth Innovation Promotion Association of the Chinese Academy of Sciences (2019283)
- National Natural Science Foundation of China (81903548, 81690265, 81803444, 81521005, 32070927)
This publication has 51 references indexed in Scilit:
- Nanoparticulate Delivery of Cancer Cell Membrane Elicits Multiantigenic Antitumor ImmunityAdvanced Materials, 2017
- Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy LandscapeTrends in Immunology, 2017
- Cancer‐Cell‐Biomimetic Nanoparticles for Targeted Therapy of Homotypic TumorsAdvanced Materials, 2016
- Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic ImmunotherapyNano Letters, 2016
- Long Circulation Red‐Blood‐Cell‐Mimetic Nanoparticles with Peptide‐Enhanced Tumor Penetration for Simultaneously Inhibiting Growth and Lung Metastasis of Breast CancerAdvanced Functional Materials, 2016
- A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cellsScience, 2015
- Clinical use of dendritic cells for cancer therapyThe Lancet Oncology, 2014
- Targeting Dendritic Cells: The Role of Specific Receptors in the Internalization of Polymer CapsulesAdvanced Healthcare Materials, 2013
- The interactions between pristine graphene and macrophages and the production of cytokines/chemokines via TLR- and NF-κB-related signaling pathwaysBiomaterials, 2012
- Inhibition of α4 integrin mediated adhesion was involved in the reduction of B16-F10 melanoma cells lung colonization in C57BL/6 mice treated with Gambogic acidEuropean Journal of Pharmacology, 2008